Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort
View ORCID ProfileRobert W Aldridge, View ORCID ProfileAlexei Yavlinsky, View ORCID ProfileVincent Nguyen, Max T Eyre, View ORCID ProfileMadhumita Shrotri, View ORCID ProfileAnnalan M D Navaratnam, View ORCID ProfileSarah Beale, Isobel Braithwaite, View ORCID ProfileThomas Byrne, Jana Kovar, View ORCID ProfileEllen Fragaszy, View ORCID ProfileWing Lam Erica Fong, View ORCID ProfileCyril Geismar, View ORCID ProfileParth Patel, Alison Rodger, Anne M Johnson, View ORCID ProfileAndrew Hayward on behalf of the Virus Watch study
doi: https://doi.org/10.1101/2021.11.05.21265968
Robert W Aldridge
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
Alexei Yavlinsky
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
Vincent Nguyen
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
2Institute of Epidemiology and Health Care, University College London, London, UK
Max T Eyre
3Centre of Health Informatics, Computing and Statistics, Lancaster Medical School, Lancaster University, Lancaster, LA1 4YW, UK
4Liverpool School of Tropical Medicine, Liverpool, UK
Madhumita Shrotri
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
Annalan M D Navaratnam
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
2Institute of Epidemiology and Health Care, University College London, London, UK
Sarah Beale
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
2Institute of Epidemiology and Health Care, University College London, London, UK
Isobel Braithwaite
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
Thomas Byrne
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
Jana Kovar
2Institute of Epidemiology and Health Care, University College London, London, UK
Ellen Fragaszy
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
5Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
Wing Lam Erica Fong
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
Cyril Geismar
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
2Institute of Epidemiology and Health Care, University College London, London, UK
Parth Patel
1Centre for Public Health Data Science, Institute of Health Informatics, University College London, UK
Alison Rodger
6Institute for Global Health, University College London, London, UK
Anne M Johnson
6Institute for Global Health, University College London, London, UK
Andrew Hayward
3Centre of Health Informatics, Computing and Statistics, Lancaster Medical School, Lancaster University, Lancaster, LA1 4YW, UK
Article usage
Posted November 09, 2021.
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort
Robert W Aldridge, Alexei Yavlinsky, Vincent Nguyen, Max T Eyre, Madhumita Shrotri, Annalan M D Navaratnam, Sarah Beale, Isobel Braithwaite, Thomas Byrne, Jana Kovar, Ellen Fragaszy, Wing Lam Erica Fong, Cyril Geismar, Parth Patel, Alison Rodger, Anne M Johnson, Andrew Hayward
medRxiv 2021.11.05.21265968; doi: https://doi.org/10.1101/2021.11.05.21265968
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort
Robert W Aldridge, Alexei Yavlinsky, Vincent Nguyen, Max T Eyre, Madhumita Shrotri, Annalan M D Navaratnam, Sarah Beale, Isobel Braithwaite, Thomas Byrne, Jana Kovar, Ellen Fragaszy, Wing Lam Erica Fong, Cyril Geismar, Parth Patel, Alison Rodger, Anne M Johnson, Andrew Hayward
medRxiv 2021.11.05.21265968; doi: https://doi.org/10.1101/2021.11.05.21265968
Subject Area
Subject Areas
- Addiction Medicine (325)
- Allergy and Immunology (640)
- Anesthesia (170)
- Cardiovascular Medicine (2434)
- Dermatology (208)
- Emergency Medicine (383)
- Epidemiology (11861)
- Forensic Medicine (10)
- Gastroenterology (706)
- Genetic and Genomic Medicine (3807)
- Geriatric Medicine (353)
- Health Economics (643)
- Health Informatics (2449)
- Health Policy (947)
- Hematology (347)
- HIV/AIDS (802)
- Medical Education (375)
- Medical Ethics (105)
- Nephrology (406)
- Neurology (3562)
- Nursing (201)
- Nutrition (534)
- Oncology (1852)
- Ophthalmology (542)
- Orthopedics (224)
- Otolaryngology (291)
- Pain Medicine (235)
- Palliative Medicine (68)
- Pathology (453)
- Pediatrics (1050)
- Primary Care Research (426)
- Public and Global Health (6232)
- Radiology and Imaging (1309)
- Respiratory Medicine (841)
- Rheumatology (385)
- Sports Medicine (328)
- Surgery (413)
- Toxicology (51)
- Transplantation (174)
- Urology (148)